Your browser doesn't support javascript.
loading
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
D'Angelo, Sandra P; Lebbé, Celeste; Mortier, Laurent; Brohl, Andrew S; Fazio, Nicola; Grob, Jean-Jacques; Prinzi, Natalie; Hanna, Glenn J; Hassel, Jessica C; Kiecker, Felix; Georges, Sara; Ellers-Lenz, Barbara; Shah, Parantu; Güzel, Gülseren; Nghiem, Paul.
Afiliación
  • D'Angelo SP; Memorial Sloan Kettering Cancer Center, New York, New York, USA dangelos@mskcc.org.
  • Lebbé C; Weill Cornell Medical College, New York, New York, USA.
  • Mortier L; AP-HP Dermatology and CIC, INSERM U976, Saint Louis Hospital, Université de Paris, Paris, France.
  • Brohl AS; Dermatology Clinic, CARADERM and University of Lille, INSERM U1189, Lille Hospital-Claude Huriez Hospital, Lille Cedex, France.
  • Fazio N; Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Grob JJ; European Institute of Oncology, IEO, IRCCS, Milan, Italy.
  • Prinzi N; AP-HM Hospital, Aix-Marseille University, Marseille, France.
  • Hanna GJ; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Hassel JC; Head and Neck Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Kiecker F; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Georges S; Charité Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
  • Ellers-Lenz B; EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
  • Shah P; Global Biostatistics, Merck KGaA, Darmstadt, Germany.
  • Güzel G; EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
  • Nghiem P; Clinical Development, Merck KGaA, Darmstadt, Germany.
J Immunother Cancer ; 9(7)2021 07.
Article en En | MEDLINE | ID: mdl-34301810
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células de Merkel / Biomarcadores de Tumor / Anticuerpos Monoclonales Humanizados / Inmunoterapia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células de Merkel / Biomarcadores de Tumor / Anticuerpos Monoclonales Humanizados / Inmunoterapia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos